U.S. Government to Pay Moderna $176 Million to Develop mRNA Flu Vaccine
By Robin Foster HealthDay Reporter
TUESDAY, July 2, 2024 (HealthDay News) -- U.S. health officials announced Tuesday that the federal government will pay Moderna $176...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
Detection rates appear to increase during nonacute office visits
Racial Differences Seen in Financial Hardship Among Older Cancer Survivors
Income and area-level disadvantage are the largest contributors to racial differences
CDC Strengthens RSV Vaccine Advice for Those Over 75
By Robin Foster HealthDay Reporter
THURSDAY, June 27, 2024 (HealthDay News) -- In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all...
Concerns of Listeria Contamination Prompt Nationwide Ice Cream Recall
No illnesses have been reported to date
For the First Time Since the Pandemic, Pedestrian Death Rates Fall in the U.S.
Rates are still above prepandemic levels, however
Summer COVID Cases Are Rising Across America
By Robin Foster HealthDay Reporter
TUESDAY, June 25, 2024 (HealthDay News) -- As scorching summer temperatures drive Americans indoors and millions travel for vacations and...
Hospital Nursing Resources Tied to COVID-19 Survival
Findings for both in-hospital death and 30-day postdischarge mortality
FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine
Company says vaccine covers serotypes responsible for approximately 84 percent of invasive pneumococcal disease in adults ages 50 years and older
Nonphysician-Implemented Multifaceted Intervention Beneficial in HTN
Significant reductions seen in total CVD, all-cause mortality for those aged 60 years and older; significant reductions also seen for those younger than 60 years
